The World Health Organization (WHO) this week prequalified the four-dose, multi-dose vial (MDV) for Pfizer Inc.’s Prevenar 13. Read More »

Namzaric approved as a combination therapy for moderate to severe Alzheimer's patients. Read More »

Extended-release Belviq XR tablets approved for use with low-calorie diet and exercise plan. Read More »

Allergan recently announced that it has surpassed its goal of donating $1 million worth of REFRESH eye drops to first responders around the country.  Read More »

Encouraging test results in bioavailability of therapeutically equivalent dose used for COPD treatment. Read More »

Lannett Company, Inc. recently announced that an Acceptable for Filing letter has been issued to its strategic partner Sparsha Pharma USA, Inc. from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System. Read More »

Ionis Pharmaceuticals, Inc. recently announced $10 million in earnings from Janssen Biotech Inc. after licensing the drug, INOIS-JBI1-2.5Rx, which is designed to hinder an undisclosed target in the gastrointestinal (GI) tract that is used to treat GI autoimmune disease. Read More »

Ajanta Pharma USA Inc., an Ajanta Pharm Ltd subsidiary, recently announced that it has launched the generic form of Zegerid Capsules, called Omeprazole and Sodium Bicarbonate Capsules, in the United State Read More »

Cigna has responded to the U.S. Department of Justice’s (DOJ) decision to challenge its merger with Anthem. Read More »

Spark Therapeutics and Pfizer Inc. recently announced that SPK-9001 has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA).  Read More »

Two high-cost arthritis medications — one the world’s best-selling drug — may soon make way for generic equivalents following preliminary committee approval, but the Food and Drug Administration must still decide whether the products are fully interchangeable. Read More »

DexCom recently announced that the U.S. Food and Drug Administration’s (FDA) Clinical Chemistry and Clinical Toxicology Devices Panel has voted to approve the DexCom G5 Mobile CGM system’s proposed non-adjunctive indication.  Read More »

The Kroger Co. recently announced an agreement had been reached with Axium Pharmacy Holdings Inc. that will allow Kroger to acquire the outstanding shares of Modern HC Holdings Inc. (ModernHealth).  Read More »

CVS Health has released naloxone, an opioid overdose-reversal medication, for sale without the need of a prescription in all CVS Pharmacy locations in Texas. Read More »

Defense spending bill stalled in Congress; fifth filibuster in two years. Read More »

Arizona Oncology recently broke ground during a ceremony celebrating its new cancer treatment center in East Valley. Read More »

he Office of the National Coordinator for Health Information Technology (ONC), run by the U.S. Department of Health and Human Services (HHS), made a joint announcement with the Assistant Secretary for Preparedness and Response (ASPR) establishing funding opportunities for an Information Sharing and Analysis Organization (ISAO) for both the health care and public health sectors. Read More »

Arizona Oncology is championing SpaceOar hydrogel, a new tool that has proven to protect patients with prostate cancer from the adverse effects of radiation therapy.  Read More »

Cynosure recently announced that SculpSure has received marketing approval from the Korean Ministry of Food and Drug Safety (MFDS) for non-invasive lipolysis of the abdomen and flanks. Read More »

Clear side Biomedical Inc. recently released the reports from its Phase II TANZANITE clinical trial showing top-line data from the study.  Read More »